Prudential Financial’s Kronos Bio KRON Stock Holding History

Prudential Financial’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,400	Closed	-$29.2K	–	2477
2025 Q1	$29.2K	Sell	35,400 -20,400	-37%	-$19.6K	﹤0.01%	2234
2024 Q4	$53K	Hold	55,800	–	–	﹤0.01%	2205
2024 Q3	$55.8K	Hold	55,800	–	–	﹤0.01%	2637
2024 Q2	$69.2K	Buy	+55,800	New	+$56.8K	﹤0.01%	2579
2023 Q3	–	Sell	-22,800	Closed	-$39.2K	–	2649
2023 Q2	$39.2K	Buy	+22,800	New	+$36.2K	﹤0.01%	2557

Prudential Financial's KRON Position: Q2 2025 in Review

Prudential Financial sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 35,400 shares — an estimated $29.2K sold.

Prudential Financial first reported a position in KRON in Q2 2023 and held it in 5 quarters. The position peaked at $69.2K in Q2 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

Prudential Financial reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
Prudential Financial sold 35,400 Kronos Bio shares in Q2 2025, an estimated $29.2K.
Prudential Financial first reported a position in Kronos Bio in Q2 2023 and held it in 5 quarters.
Prudential Financial's Kronos Bio position peaked at $69.2K in Q2 2024.
0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.